Sancho-Saldaña, A.; Gil-Sánchez, A.; González-Mingot, C.; Peralta, S.; Solana, M.J.; Torres, P.; Juanes, A.; Quibus, L.; Ruiz, E.; Sanpedro, E.;
et al. Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study. J. Clin. Med. 2023, 12, 7243.
https://doi.org/10.3390/jcm12237243
AMA Style
Sancho-Saldaña A, Gil-Sánchez A, González-Mingot C, Peralta S, Solana MJ, Torres P, Juanes A, Quibus L, Ruiz E, Sanpedro E,
et al. Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study. Journal of Clinical Medicine. 2023; 12(23):7243.
https://doi.org/10.3390/jcm12237243
Chicago/Turabian Style
Sancho-Saldaña, Agustín, Anna Gil-Sánchez, Cristina González-Mingot, Silvia Peralta, Maria Jose Solana, Pascual Torres, Alba Juanes, Laura Quibus, Emilio Ruiz, Eduardo Sanpedro,
and et al. 2023. "Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study" Journal of Clinical Medicine 12, no. 23: 7243.
https://doi.org/10.3390/jcm12237243
APA Style
Sancho-Saldaña, A., Gil-Sánchez, A., González-Mingot, C., Peralta, S., Solana, M. J., Torres, P., Juanes, A., Quibus, L., Ruiz, E., Sanpedro, E., Quirant-Sánchez, B., Martínez-Cáceres, E., Ramo Tello, C., Presas-Rodríguez, S., García Rubio, S., Baron, B. P., Ramió-Torrentà, L., Sotoca, J., González-Suárez, I.,
... Brieva, L.
(2023). Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study. Journal of Clinical Medicine, 12(23), 7243.
https://doi.org/10.3390/jcm12237243
